← Back to Search

Behavioural Intervention

Virtual Reality Intervention for Domestic Violence

N/A
Recruiting
Led By Nicholas Thomson
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Be older than 18 years old
Must not have
Under 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to baseline assessment, from baseline to 3-month follow-up, and from 3-month follow-up to the 6-month follow-up.

Summary

"This trial aims to develop and test a virtual reality program called Brief Violence Intervention-Virtual Reality (BVI-VR) to reduce firearm-related violence and injuries among victims of violence. The study will use

Who is the study for?
This trial is for adults who have been injured due to violence and are at VCU Health. It's designed to see if a new virtual reality program can help reduce gun-related violence, re-injury, or death in these individuals. The study will exclude certain participants based on criteria not specified here.
What is being tested?
The study tests a Virtual Reality intervention called BVI-VR against the usual treatment methods (TAU) to prevent further gun-related incidents among violently injured adults. Participants will be randomly assigned to one of the two groups.
What are the potential side effects?
Since this trial involves a non-medical intervention (virtual reality), typical drug side effects are not expected. However, VR experiences may cause discomfort like dizziness or nausea in some people.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to baseline assessment, from baseline to 3-month follow-up, and from 3-month follow-up to the 6-month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to baseline assessment, from baseline to 3-month follow-up, and from 3-month follow-up to the 6-month follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Firearm criminal conviction and arrests/ Criminal Background Checks
Firearm-related violence /The gun violence questionnaire
Gun Behaviors and Beliefs Scale
+1 more
Secondary study objectives
Firearm-related mortality/ Hospital data; Virginia Department of Health; National Death Index
Firearm-related re-injury/ Hospital data: Virginia Department of Health
Firearm-related re-injury/ Self-report

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention GroupExperimental Treatment1 Intervention
Patients randomized into the BVI-VR group will answer questions about the session content and the rationale for the content. Their responses will provide an estimate of engagement providing a better understanding of treatment fidelity.
Group II: Treatment as Usual (TAU) GroupPlacebo Group1 Intervention
The treatment-as-usual (TAU) group will receive a community resource brochure (the same one that is provided at the end of BVI-VR). This brochure provides contact detail for services in the local area.

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
887 Previous Clinical Trials
21,996,373 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
714 Previous Clinical Trials
22,888,175 Total Patients Enrolled
Nicholas ThomsonPrincipal InvestigatorVirginia Commonwealth University
3 Previous Clinical Trials
976 Total Patients Enrolled
~147 spots leftby Sep 2026